Department Of Microbiology 3
101. A retrospective study of animal leptospirosis in Kazakhstan
102. Composition of the Microbiome of Rainbow Trout (Oncorhynchus mykiss) and Siberian Sturgeon (Acipenser baerii) and Options for its Correction with Probiotics
103. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
104. Transcriptomics and methylomics study on the effect of iodine-containing drug FS-1 on Escherichia coli ATCC BAA-196
105. The effectiveness of training on auscultation of heart with a simulator of cardiology in medical students
106. Specific Features of Immune Response in Patients with Different Asthma Endotypes Following Immunization with a Conjugate Pneumococcal Vaccine
107. Mn3O4 Nanocrystal-Induced Eryptosis Features Ca2+ Overload, ROS and RNS Accumulation, Calpain Activation, Recruitment of Caspases, and Changes in the Lipid Order of Cell Membranes
108. Acid-Base and Photocatalytic Properties of the CeO2-Ag Nanocomposites
109. A bibliometric analysis of the impact of COVID-19 vaccines on the immune system (2020-2024)
110. A comparison of Gam-COVID-Vac vaccination and non-vaccination on neurological symptoms and immune response in post-COVID-19 syndrome
111. An Overview of Hexavalent Chromium-Induced Necroptosis, Pyroptosis, and Ferroptosis
112. An Overview of Hexavalent Chromium-Induced Necroptosis, Pyroptosis, and Ferroptosis
113. An Overview of Hexavalent Chromium-Induced Necroptosis, Pyroptosis, and Ferroptosis
114. Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation
115. Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation
116. Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation
117. Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation
118. Evolution of oxidative stress research in liver cirrhosis: A 30-Year bibliometric review (1992–2025)
119. The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status
120. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
121. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
122. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
123. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
124. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
125. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
126. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
127. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
128. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
129. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
130. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study
131. Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
132. Impact of QazVac vaccination on clinical manifestations and immune responses in post—COVID syndrome: a cross-sectional study
133. Primary Care for Gestational Diabetes: A Bibliometric Analysis of Publications from 1991 to 2024
134. Wheat Straw Processing Effect Study on Their Enzymatic Hydrolysis by Trichoderma viride and Aspergillus аwamori Cultures
135. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
136. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
137. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
138. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
139. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
140. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
141. Analysis of the Antimicrobial and Anti-Biofilm Activity of Natural Compounds and Their Analogues against Staphylococcus aureus Isolates
142. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
143. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
144. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
145. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
146. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
147. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
148. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
149. Adsorption performance of Enterobacter cloacae towards U(VI) ion and application of Enterobacter cloacae/carbon nanotubes to preconcentration and determination of low-levels of U(VI) in water samples
150. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
1 2 3 4 5 6